Noticias de Eulerpool ESSA Pharma

ESSA Pharma Eulerpool-AFX

ESSA Pharma Noticias de Acciones

ESSA Pharma es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de ESSA Pharma.

• 29 de mayo ·

  SeekingAlpha
  ESSA Pharma's Speculative Buy Potential: Masofaniten Promise For Prostate Cancer
• 28 de mayo ·

  Yahoo
  EPIX: Updated Data from Phase 1 Trial of Masofaniten and Enzalutamide Expected in 2H24
• 21 de mayo ·

  Yahoo
  Insider Stock Buying Reaches US$709.0k On ESSA Pharma
• 20 de mayo ·

  InvestorPlace
  Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
• 16 de mayo ·

  TipRanks
  Oppenheimer Sticks to Its Buy Rating for ESSA Pharma (EPIX)
• 14 de mayo ·

  InvestorPlace
  EPIX Stock Earnings: ESSA Pharma Misses EPS for Q2 2024
• 14 de mayo ·

  TipRanks
  Buy Rating Endorsed for ESSA Pharma on Robust Pipeline and Market Expansion Potential
• 14 de mayo ·

  Yahoo
  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024
• 14 de mayo ·

  TipRanks
  ESSA Pharma’s Promising Prostate Cancer Trial Updates
• 14 de mayo ·

  Seeking Alpha
  ESSA Pharma GAAP EPS of -$0.20 misses by $0.01